SB-435495 ditartrate

Modify Date: 2024-04-11 16:33:57

SB-435495 ditartrate structure	Common Name	SB-435495 ditartrate
	CAS Number	304694-43-7	Molecular Weight	1021.00
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₄₆H₅₂F₄N₆O₁₄S	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of SB-435495 ditartrate

SB-435495 ditartrate is a potent, selective, reversible, non-covalent and orally active Lp-PLA2 inhibitor with an IC50 of 0.06 nM[1][3].

Name	SB-435495 ditartrate

Description	SB-435495 ditartrate is a potent, selective, reversible, non-covalent and orally active Lp-PLA2 inhibitor with an IC50 of 0.06 nM[1][3].
Related Catalog	Signaling Pathways >> Metabolic Enzyme/Protease >> Phospholipase Research Areas >> Metabolic Disease
Target	Lp-PLA2:0.06 nM (IC50)
In Vitro	SB-435495 ditartrate 抑制 CYP450 3A4 的 IC50 为 10 μM，膜通透性为 0.017 cm/h[1]。 SB-435495 (5 μM; 24 h) ditartrate 显著抑制 Lp-PLA2 蛋白的表达，同时提高 oxLDL 暴露 HUVECs 中 AMPKα 和磷酸化-AMPKα (T172) 的表达水平[2]。 SB-435495 (5 μM; 24-72 h) ditartrate 在 oxLDL 暴露 HUVECs 中显著增加细胞活力和 NO 表达，显著降低 ET-1 表达[2]。 Western Blot Analysis[2] Cell Line: oxLDL-exposed human umbilical vein endothelial cells Concentration: 5 μM Incubation Time: 24 h Result: The expression of Lp-PLA2 protein was significantly inhibited. Increased the expression levels of AMPKα and phosphorylated-AMPKα (T172). Cell Viability Assay[2] Cell Line: oxLDL-exposed human umbilical vein endothelial cells Concentration: 5 μM Incubation Time: 24, 48 and 72 h Result: Significantly increased cell viability.
In Vivo	SB-435495 (10 mg/kg; p.o.; once) ditartrate 抑制 WHHL 兔血浆 Lp-PLA2 [1]。 SB-435495 (10 mg/kg; i.p.; daily for 28 days) ditartrate 在 Streptozotocin (HY-13753) 糖尿病褐挪威大鼠中有效抑制血视网膜屏障 (BRB) 的破坏[3]。 Animal Model: WHHL rabbit[1] Dosage: 10 mg/kg Administration: Oral, once Result: Inhibited plasma Lp-PLA2 in the WHHL rabbit.
References	[1]. Blackie JA, et al. The discovery of SB-435495. A potent, orally active inhibitor of lipoprotein-associated phospholipase A(2) for evaluation in man. Bioorg Med Chem Lett. 2002 Sep 16;12(18):2603-6. [2]. Yang L, et al. AMP-activated protein kinase mediates the effects of lipoprotein-associated phospholipase A2 on endothelial dysfunction in atherosclerosis. Exp Ther Med. 2017 Apr;13(4):1622-1629. [3]. Canning P, et al. Lipoprotein-associated phospholipase A2 (Lp-PLA2) as a therapeutic target to prevent retinal vasopermeability during diabetes. Proc Natl Acad Sci U S A. 2016 Jun 28;113(26):7213-8.

Molecular Formula	C₄₆H₅₂F₄N₆O₁₄S
Molecular Weight	1021.00

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

Shanghai Nianxing Industrial Co., Ltd
China
Product Name: Palmitic acid
Price: Check
Purity: 98.0%
Delivery: 10 Day
Contact: Yang
Email: sales@echemcloud.com